Three new assays were presented in posters at April's Clinical Virology Symposium.
Scientists in British Columbia are setting up a genomic surveillance system for avian influenza.
In Science this week: self-assembly of DNA components in solution, and more.
Genome sequences from hundreds of H7N9 isolates in China traced the movement of viruses responsible for a second wave of human infections in the country.
The RT-PCR/ESI-MS system showed similar sensitivity and specificity to tests from Cepheid and Hologic.
The firm is focused on moving more of its business into the molecular diagnostics market, and it believes the recent CLIA waiver for its Alere i platform provides it with a market opportunity not available to competitors.
With overlapping technologies, some firms pursue parallel human and animal health diagnostics development, but cost constraints and regulatory dynamics differ. Part one of a two-part series.
The waiver opens up a significant new opportunity for Alere within the physician office market, according to a company executive.
The Alere i Influenza A&B assay was originally cleared by FDA in June and the CLIA waiver means the test will be available in a wider variety of healthcare settings.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.